The invention relates to the field of organic and medicinal chemistry, and molecular biology, and concerns a method for the preparation of a new class of telomerase-inhibiting compounds, which can be utilized for studying telomerases and catalytic sub-units of telomerases, and reverse transcriptases, and foe studying and treating neoplastic and viral diseases. Telomerase-inhibiting coordination compounds of derivatives of imidazol-4-one are characterized by general formula (1).
本发明涉及有机
化学、药物
化学和
分子生物学领域,涉及一种新型端粒酶抑制化合物的制备方法,该化合物可用于研究端粒酶、端粒酶催化亚单位和逆转录酶,以及研究和治疗肿瘤和病毒性疾病。
咪唑-4-酮衍
生物的端粒酶抑制配位化合物的特征为通式(1)。